Author:
Wozniak D.,Rummel-Kluge C.
Publisher
Springer International Publishing
Reference31 articles.
1. Brooks GW. Withdrawal from neuroleptic drugs. Am J Psychiatry. 1959;115(10):931–2. https://doi.org/10.1176/ajp.115.10.931.
2. Ceraso A, Lin JJ, Schneider-Thoma J, Siafis S, Tardy M, Komossa K, et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2020;8:CD008016. https://doi.org/10.1002/14651858.CD008016.pub3.
3. Dold M, Fugger G, Aigner M, Lanzenberger R, Kasper S. Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Res. 2015;166(1–3):187–93. https://doi.org/10.1016/j.schres.2015.04.024.
4. Gaebel W, Hasan A, Falkai P, editors. S3-Leitlinie Schizophrenie. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde; Springer-Verlag GmbH. 1. Auflage 2019. Berlin/Heidelberg: Springer; 2019.
5. Helfer B, Samara MT, Huhn M, Klupp E, Leucht C, Zhu Y, et al. Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis. Am J Psychiatry. 2016;173(9):876–86. https://doi.org/10.1176/appi.ajp.2016.15081035.